BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19153362)

  • 1. Limited cutaneous systemic sclerosis induced by paclitaxel in a patient with breast cancer.
    Kawakami T; Tsutsumi Y; Soma Y
    Arch Dermatol; 2009 Jan; 145(1):97-8. PubMed ID: 19153362
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer.
    De Angelis R; Bugatti L; Cerioni A; Del Medico P; Filosa G
    Clin Rheumatol; 2003 Feb; 22(1):49-52. PubMed ID: 12605319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody.
    Adachi A; Horikawa T
    J Dermatol; 2007 Jul; 34(7):473-6. PubMed ID: 17584326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subungal abcesses secondary to paclitaxel.
    Albares MP; Belinchón I; Pascual JC; Vergara G; Blanes M; Betlloch I
    Dermatol Online J; 2003 Aug; 9(3):16. PubMed ID: 12952763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurses should monitor cutaneous toxicity in chemotherapy regimens with paclitaxel.
    Knobf MT; Staugaard C
    Oncol Nurs Forum; 1997 Sep; 24(8):1328. PubMed ID: 9380582
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety evaluation of paclitaxel injection NK in adjuvant therapy for breast cancer].
    Takahara S; Yamamoto H; Tokushima Y; Shiba E
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1851-6. PubMed ID: 19920387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: paclitaxel-induced myocardial ischemia.
    Soe MS; Berkman A; Mardelli TJ
    Md Med J; 1996 Jan; 45(1):41-3. PubMed ID: 8569460
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystoid macular edema secondary to nab-paclitaxel therapy.
    Murphy CG; Walsh JB; Hudis CA; Lake D; Theodoulou M
    J Clin Oncol; 2010 Nov; 28(33):e684-7. PubMed ID: 20805460
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral neuropathy in a woman with breast cancer.
    Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA
    J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
    Altundag O; Altundag K; Gundeslioglu O; Silay YS; Ersoy Y
    Med Hypotheses; 2006; 66(4):857-8. PubMed ID: 16039067
    [No Abstract]   [Full Text] [Related]  

  • 12. Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer.
    Cohen PR
    J Drugs Dermatol; 2009 Jan; 8(1):61-4. PubMed ID: 19180897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-induced radiation recall dermatitis.
    McCarty MJ; Peake MF; Lillis P; Vukelja SJ
    Med Pediatr Oncol; 1996 Sep; 27(3):185-6. PubMed ID: 8699997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-induced cardiotoxicity. An ultrastructural study.
    Shek TW; Luk IS; Ma L; Cheung KL
    Arch Pathol Lab Med; 1996 Jan; 120(1):89-91. PubMed ID: 8554453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-induced nail changes: possible role of its vehicle (Cremophor EL).
    Minutilli E; Izzo F; Natoli G; Psaila A; Di Filippo F; Terzoli E
    Eur J Dermatol; 2006; 16(6):693-4. PubMed ID: 17229616
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer.
    Ohashi A; Minagawa A; Ashida A; Koga H; Uhara H; Okuyama R
    J Dermatol; 2015 Dec; 42(12):1198-9. PubMed ID: 26333146
    [No Abstract]   [Full Text] [Related]  

  • 18. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy-induced acral erythema sparing the palms.
    Housholder AL; Adams BB
    J Am Acad Dermatol; 2012 Sep; 67(3):e116-7. PubMed ID: 22890739
    [No Abstract]   [Full Text] [Related]  

  • 20. Study finds that hormone status may predict chemotherapy's effectiveness on breast cancer.
    McBride D
    ONS Connect; 2008 Jan; 23(1):25. PubMed ID: 18284079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.